PolyPeptide Group AG
PolyPeptide Group AG is a Swiss-based contract development and manufacturing organization (CDMO) specializing in the production of peptide active pharmaceutical ingredients for the global pharmaceutical and biotechnology industry. The company operates multiple GMP-certified manufacturing facilities across Europe and North America, serving a broad range of innovator and generic drug customers. Listed on the SIX Swiss Exchange, PolyPeptide focuses exclusively on peptide synthesis, making it one of the largest independent peptide CDMOs in the world.
Last Dividend
0.30
CHF · 2022-04-28
5Y Growth
—
CAGR
Frequency
None
Years Paid
1
consecutive
Not Cut
—
consecutive yrs
Grown
—
consecutive yrs
Listings
| Exchange | Ticker | Currency |
|---|---|---|
| SIX primary | PPGN | CHF |
Annual Dividends
Annual dividend per share · 1 years of data
Dividend History
| Ex-Date ▼ | Pay-Date ▼ | Amount ▼ | Type ▼ |
|---|---|---|---|
| 28.04.2022 | 02.05.2022 | 0.30 CHF | Ordinary |